Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
J Cardiovasc Pharmacol
    May 2024
  1. LUZ DE CASTRO A, Ortiz VD, Hickmann AR, Lacerda DS, et al
    EFFECTS OF PTEROSTILBENE ON HEART AND LUNG OXIDATIVE STRESS PARAMETERS IN TWO EXPERIMENTAL MODELS OF CARDIOVASCULAR DISEASE: MYOCARDIAL INFARCTION AND PULMONARY ARTERIAL HYPERTENSION.
    J Cardiovasc Pharmacol. 2024 May 4. doi: 10.1097/FJC.0000000000001572.
    >> Share

    March 2024
  2. CONZATTI A, Colombo R, Siqueira R, Campos-Carraro C, et al
    Sulforaphane improves redox homeostasis and right ventricular contractility in a model of pulmonary hypertension.
    J Cardiovasc Pharmacol. 2024 Mar 14. doi: 10.1097/FJC.0000000000001557.
    >> Share

  3. RIBEIRO PONTES CN, de Sa Martins de Bessa A, Macedo LM, Ferreira-Junior MD, et al
    ANGIOTENSIN-(1-7) TREATMENT EARLY IN LIFE PREVENTS CARDIAC HYPERTROPHY IN ADULT HYPERTENSIVE RATS.
    J Cardiovasc Pharmacol. 2024 Mar 12. doi: 10.1097/FJC.0000000000001530.
    >> Share

    February 2024
  4. JIANG K, Jia Y, Chen L, Huang F, et al
    Association of IL-17 Inhibitors with Hypertension in Patients with Autoimmune Diseases: A Systematic Review and Meta-analysis on Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2024 Feb 27. doi: 10.1097/FJC.0000000000001547.
    >> Share

    January 2024
  5. KUMARI K, Vishwakarma VK, Kumar K, Mridha AR, et al
    Effect of benidipine alone and in combination with bosentan and sildenafil in amelioration of pulmonary arterial hypertension in experimental model in rats.
    J Cardiovasc Pharmacol. 2024 Jan 17. doi: 10.1097/FJC.0000000000001541.
    >> Share

  6. LI J, He X, Liu F, Zheng X, et al
    Tumor Necrosis Factor-alpha-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
    J Cardiovasc Pharmacol. 2024;83:73-85.
    >> Share

    December 2023
  7. ATEFIPOUR N, Dianat M, Badavi M, Radan M, et al
    The Role of Rosmarinic Acid in the Protection against Inflammatory Factors in Rats Model with Monocrotaline-Induced Pulmonary Hypertension: Investigating the Signaling Pathway of NFkappaB, OPG, Runx2, and P-selectin in Heart.
    J Cardiovasc Pharmacol. 2023 Dec 26. doi: 10.1097/FJC.0000000000001534.
    >> Share

    November 2023
  8. KELLY MS, Dacey A, Siana A, Ojeda J, et al
    Efficacy and Safety of a polypill to reduce cardiovascular events: A review of clinical trials.
    J Cardiovasc Pharmacol. 2023 Nov 4. doi: 10.1097/FJC.0000000000001508.
    >> Share

    September 2023
  9. LIU R, Staruschenko A
    Matrix Metalloproteinase 2 is crucial for hypertension- and hyperglycemia-induced kidney injury independent of blood pressure.
    J Cardiovasc Pharmacol. 2023 Sep 28. doi: 10.1097/FJC.0000000000001488.
    >> Share

  10. BROCKMOLLER J, Ivanoski S, Hundack L, Blohm JH, et al
    Clinical and hemodynamic improvement in pulmonary hypertension after switching to sacubitril/valsartan in heart failure patients with preserved ejection fraction.
    J Cardiovasc Pharmacol. 2023 Sep 1. doi: 10.1097/FJC.0000000000001477.
    >> Share

    August 2023
  11. HIRATA T, Fan F, Fan L, Amin G, et al
    Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-Induced Nephropathy.
    J Cardiovasc Pharmacol. 2023 Aug 25. doi: 10.1097/FJC.0000000000001473.
    >> Share

  12. CERON CS, Luizon MR, Palei AC
    The Potential Role of Visfatin in Mediating Vascular Dysfunction and Hypertension.
    J Cardiovasc Pharmacol. 2023 Aug 9. doi: 10.1097/FJC.0000000000001457.
    >> Share

  13. KAPLAN A, Lakkis B, El-Samadi L, Karaayvaz EB, et al
    Cooling Down Inflammation in the Cardiovascular System via the Nicotinic Acetylcholine Receptor.
    J Cardiovasc Pharmacol. 2023 Aug 4. doi: 10.1097/FJC.0000000000001455.
    >> Share

    October 2022
  14. KANG L, Liu X, Li Z, Li X, et al
    Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn.
    J Cardiovasc Pharmacol. 2022 Oct 1. pii: 00005344-990000000-00118.
    >> Share

  15. GUHA A, Gong Y, DeRemer D, Owusu-Guha J, et al
    Cardiometabolic Consequences of Targeted Anticancer Therapies.
    J Cardiovasc Pharmacol. 2022;80:515-521.
    >> Share

    September 2022
  16. SWAMI VETHA BS, Byrum R, Peele K, Diz D, et al
    Functional Significance of Angiotensin Receptor Type 2 in the Neuroplasticity of Autonomic Ganglia in (mRen2)27 Transgenic Hypertensive Rats.
    J Cardiovasc Pharmacol. 2022 Sep 16. pii: 00005344-990000000-00116.
    >> Share


  17. Sacubitril/Valsartan Improves Sexual Function and Fibrosis of the Clitoral and Vaginal Tissues in Female Spontaneously Hypertensive Rats: Erratum.
    J Cardiovasc Pharmacol. 2022;80:489.
    >> Share

    August 2022
  18. CHUQUIN D, Abbate A, Bottinor W
    Hypertension in Cancer Survivors: A Review of the Literature and Suggested Approach to Diagnosis and Treatment.
    J Cardiovasc Pharmacol. 2022 Aug 25. pii: 00005344-990000000-00110.
    >> Share

  19. YANG S, Shen W, Zhang HZ, Wang CX, et al
    Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus with Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2022 Aug 23. pii: 00005344-990000000-00107.
    >> Share

  20. D'SOUZA MS, Luu AN, Guisinger TC, Seeley SL, et al
    Regulator of G-Protein Signaling 5 Protein Deficiency Differentially Influences Blood Pressure, Vascular and Behavioral Effects in Aged Male Mice.
    J Cardiovasc Pharmacol. 2022;80:305-313.
    >> Share

    July 2022
  21. IMAM SS, El-Farrash RA, Taha AS, Saleh GA, et al
    Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
    J Cardiovasc Pharmacol. 2022 Jul 12. pii: 00005344-990000000-00081.
    >> Share

    May 2022
  22. CAI H, Fan S, Cai L, Zhu L, et al
    Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2/miR-503/PI3K/AKT axis.
    J Cardiovasc Pharmacol. 2022 May 5. pii: 00005344-990000000-00028.
    >> Share

    April 2022
  23. CHENG L, Maboh RN, Wang H, Mao GW, et al
    Naoxintong capsule activates the Nrf2/HO-1 signaling pathway and suppresses the p38alpha signaling pathway via estrogen receptors to ameliorate heart remodeling in female mice with postmenopausal hypertension.
    J Cardiovasc Pharmacol. 2022 Apr 29. pii: 00005344-990000000-00034.
    >> Share

  24. BAO M, Song Y, Wu S, Li J, et al
    The influence of hypersensitive C-reactive protein on the effect of continuous antihypertensive pharmacological therapy.
    J Cardiovasc Pharmacol. 2022 Apr 5. pii: 00005344-990000000-00017.
    >> Share

  25. CHAN TH, Tsoi MF, Yung Cheung BM
    Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study.
    J Cardiovasc Pharmacol. 2022;79:577-582.
    >> Share

    March 2022
  26. ZHUANG C, Yi G, Wang W, Sun R, et al
    Sacubitril/Valsartan Improves Sexual Function and Fibrosis of the Clitoral and Vaginal Tissues in Female Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2022 Mar 8. pii: 00005344-990000000-00003.
    >> Share

  27. JOB R, Abdul Qader M, Torres P, Al Abbasi B, et al
    Renin-Angiotensin System Blocker in COVID-19. A Single Center Study.
    J Cardiovasc Pharmacol. 2022;79:311-314.
    >> Share

  28. HAN H, Dou J, Hou Q, Wang H, et al
    Role of Circadian Rhythm and Impact of Circadian Rhythm Disturbance on the Metabolism and Disease.
    J Cardiovasc Pharmacol. 2022;79:254-263.
    >> Share

    November 2021
  29. TEMIZ-RESITOGLU M, Guden DS, Senol SP, Vezir O, et al
    Pharmacological inhibition of mTOR attenuates DOCA-salt-induced hypertension and related pathophysiology: regulation of oxidative stress, inflammation and cardiovascular hypertrophy in male rats.
    J Cardiovasc Pharmacol. 2021 Nov 23. pii: 00005344-900000000-98105.
    >> Share

    October 2021
  30. ALVES QL, Vieira da Silva Santos P, Santos WA, Dantas Damasceno SC, et al
    Unraveling the cardiac effects induced by carvacrol in spontaneously hypertensive rats: Involvement of TRPM4 and TRPM7 channels.
    J Cardiovasc Pharmacol. 2021 Oct 28. pii: 00005344-900000000-98123.
    >> Share

  31. ZHU T, Wang X, Zheng Z, Quan J, et al
    ZIP12 Contributes to Hypoxic Pulmonary Hypertension by Driving Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells.
    J Cardiovasc Pharmacol. 2021 Oct 21. pii: 00005344-900000000-98129.
    >> Share

  32. ABDELMONEM M, Ebada MA, Diab S, Ahmed MM, et al
    Efficacy of Hibiscus Sabdariffa on Reducing Blood Pressure in Patients with Mild to Moderate Hypertension: A Systematic Review and Meta-Analysis of published randomized controlled trials.
    J Cardiovasc Pharmacol. 2021 Oct 20. pii: 00005344-900000000-98127.
    >> Share

  33. ADIE SK, Abdul-Aziz AA, Ketcham SW, Moles VM, et al
    Considerations for inotrope and vasopressor use in critically ill patients with pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2021 Oct 6. pii: 00005344-900000000-98139.
    >> Share

    August 2021
  34. LUO S, Kan J, Zhang J, Ye P, et al
    Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
    J Cardiovasc Pharmacol. 2021;78:253-262.
    >> Share

    July 2021
  35. PENG M, He J, Xue Y, Yang X, et al
    The role of hypertension on the severity of COVID-19: a review.
    J Cardiovasc Pharmacol. 2021 Jul 22. pii: 00005344-900000000-98170.
    >> Share

  36. KRYSIAK R, Basiak M, Okopien B
    Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia: a pilot study.
    J Cardiovasc Pharmacol. 2021 Jul 20. pii: 00005344-900000000-98169.
    >> Share

  37. WANG Y, Wang JW, Wang Y, Yang B, et al
    Monitoring Antihypertensive Medication Adherence by LC-MS/MS: Method Establishment and Clinical Application.
    J Cardiovasc Pharmacol. 2021 Jul 9. pii: 00005344-900000000-98173.
    >> Share

    June 2021
  38. HAMMOUD S, Kurdi M, van den Bemt BJ
    Impact of Fasting on Cardiovascular Outcomes in Patients with Hypertension.
    J Cardiovasc Pharmacol. 2021 Jun 29. pii: 00005344-900000000-98181.
    >> Share

  39. WATSON K, Kukin A, Wasik AK, Shulenberger CE, et al
    Nonsteroidal Mineralocorticoid Receptor Antagonists: Exploring Role in Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2021;77:685-698.
    >> Share

    May 2021
  40. YANG S, Zhang H, Yang P, Wang C, et al
    Efficacy and Safety of LCZ696 for Short-term Management of Essential Hypertension Compared With ARBs: A Meta-analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2021;77:650-659.
    >> Share

  41. ZOUEIN FA, Altara R, Massoud GP, Booz GW, et al
    The Angiotensin II Type 1(AT1) Receptor and Cardiac Hypertrophy: Did We Have It Wrong All Along?
    J Cardiovasc Pharmacol. 2021;77:531-535.
    >> Share

    April 2021
  42. MCCOY EK, Lisenby KM
    Aprocitentan (a dual endothelin receptor antagonist) for Treatment-Resistant Hypertension.
    J Cardiovasc Pharmacol. 2021 Apr 5. pii: 00005344-900000000-98239.
    >> Share

  43. YAMAGATA K, Yamori Y
    Altered properties of neurons and astrocytes and the effects of food components in stroke-prone spontaneously hypertensive rats.
    J Cardiovasc Pharmacol. 2021 Apr 5. pii: 00005344-900000000-98237.
    >> Share

  44. GILEWSKI W, Banach J, Rogowicz D, Wolowiec L, et al
    Treatment of hypertension due to immunosuppressive therapy after solid organ transplantation - pharmacological approach.
    J Cardiovasc Pharmacol. 2021 Apr 5. pii: 00005344-900000000-98236.
    >> Share

  45. MIOTTO DS, Duchatsch F, Macedo AG, Ruiz TFR, et al
    Perindopril Reduces Arterial Pressure and Does Not Inhibit Exercise-Induced Angiogenesis in Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2021;77:519-528.
    >> Share

    March 2021
  46. RAJABI S, Najafipour H, Farsangi SJ, Joukar S, et al
    Quercetin, Perillyl alcohol and Berberine ameliorate right ventricular disorders in experimental pulmonary arterial hypertension: Effects on miR-204, miR-27a, fibrotic, apoptotic and inflammatory factors.
    J Cardiovasc Pharmacol. 2021 Mar 12. pii: 00005344-900000000-98234.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016